|
|
 |
Registry of Lobbyists - Jean-Christophe de Le Rue
To find further information on a company or organization check the Registry of Joint Stock Companies
|
|
| Registration Number | Status | | | 3171 | Active | | | Initial registration date | Last date of any changes | | 27-May-2024 | 27-May-2024 |
|
Lobbyist's Last Name
de Le Rue |
Lobbyist's First Name
Jean-Christophe |
Middle Initial
|
|
Business Address of Lobbyist
390 Rue Notre Dame O |
City
Montréal |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H2Y 1T9 |
Telephone
6138060671 |
Fax
|
| |
Business or Firm Name for Lobbyist (if applicable)
Dialogue Health Technologies Inc. |
Registry of Joint Stock Companies Number
|
Business Address of Lobbyist's Business or Firm
|
City
|
Province/State
NS |
Country
CA |
Postal/Zip Code
|
Telephone
|
Fax
|
|
| Beneficiary Name |
Beneficiary Type |
|
| Sun Life Financial |
Parent Company |
View
|
|
|
|
|
Description of Employer's Business:
Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through its team of health professionals, it serves employers and organizations who have an interest in the health and well-being of their employees, members and their families. Dialogue's Integrated Health Platform™ is a one-stop healthcare hub that centralizes all programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet. Dialogue is the first virtual care provider to receive the Accreditation Canada Primer award, a third-party validation of safety and high-level quality of care. In October 2023, Sun Life acquired Dialogue, which now operates as a standalone entity as part of Sun Life Canada. For more information, please visit the Company's website at www.dialogue.co. |
| |
|
|
|
| Description |
|
| Discussions with government officials to increase access to care through virtual care in Nova Scotia. |
View
|
|
|
|
|
|
No funding from any government or agency
|
|
No private funding related to lobbying activities
|
|
|
|
|
